Paragraph 2 F1
A statement or cover letter drawing attention to any features which are particular to the clinical trial, if required.
Annotations
Textual amendments
- F1
Sch. 3 Pt. A1 inserted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 39(3)
Notes on Schedule 3
Textual amendments
- F1
Words in Sch. 3 heading substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 39(2)